HongDuck Yun

Dr. HongDuck Yun


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
JLJisun Lim
Jisun Lim
JHJinbeom Heo
Jinbeom Heo
HJHyein Ju
Hyein Ju
JSJi-Woong Shin
Ji-Woong Shin
YKYongHwan Kim
YongHwan Kim
DSDong-Myung Shin
Dong-Myung Shin
Real-time monitoring of GSH dynamics demonstrates the functional roles of CREB1-NRF2 pathway in MSC therapeutic potency.

18 April 2024 in International Journal of Stem Cells
Verified
Journal Article
Open access
PDF file
JSJung Hyun Shin
Jung Hyun Shin
HYHwan Yeul Yu
Hwan Yeul Yu
HKHyungu Kwon
Hyungu Kwon
HYHongDuck Yun
HongDuck Yun
CRChae-Min Ryu
Chae-Min Ryu
MCMyung-Soo Choo
Myung-Soo Choo
Jung Hyun Shin, Hwan Yeul Yu, Hyungu Kwon, Hong Duck Yun, Chae-Min Ryu, Dong-Myung Shin, Myung-Soo Choo. IJSC -0001;0:. https://doi.org/10.15283/ijsc23147

Verified
Journal Article
Open access
PDF file
HYHongDuck Yun
HongDuck Yun
PGPONMARI K GURUVAIYA
PONMARI K GURUVAIYA
OLOlena Levurdiak
Olena Levurdiak
Alexei BasnakianAlexei Basnakian
Alexei Basnakian
MBMarjan Boerma
Marjan Boerma
KKKYOUNGHYUN KIM
KYOUNGHYUN KIM
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with poor prognosis and limited therapeutic options. Although epigenetic dysregulation is a hallmark of HCC, rational combinatorial targeting strategies remain incompletely defined. Here, we identify cooperative oncogenic functions of the chromatin modifiers enhancer of zeste homolog 2 (EZH2) and lysine-specific demethylase 1 (LSD1) in HCC. Analysis of the TCGA-LIHC cohort revealed that co-elevated EZH2 and LSD1 expressions are significantly associated with reduced overall survival. Gene set enrichment analysis demonstrated enrichment of Sonic Hedgehog (SHH) signaling and stress-responsive transcriptional programs in tumors with high EZH2/LSD1 expression. Functionally, dual pharmacological inhibition of EZH2 (GSK126) and LSD1 (SP2509) suppressed HCC cell proliferation, induced G1-phase arrest, and enhanced apoptosis, as evidenced by increased caspase-3/7 activity and decreased pro-caspase levels. Dual inhibition also impaired migration, invasion, tumor sphere formation, and stemness-associated gene expression. Mechanistically, co-targeting disrupted SHH signaling through the suppression of GLI1 expression. Chromatin immunoprecipitation revealed reduced EZH2, LSD1, and STAT3 occupancy at the GLI1 promoter following dual inhibition, leading to the repression of GLI1 and its downstream targets. Collectively, these findings demonstrate that EZH2 and LSD1 cooperatively sustain GLI1-dependent SHH signaling in HCC, and that dual epigenetic inhibition represents a mechanistically defined therapeutic strategy.